Vertex Pharmaceuticals: A Biopharma Behemoth Fortified by CF Dominance and a Groundbreaking Pain Pipeline
The Trump 2.0 Market Shift: Palantir Soars While Tesla Stumbles 200 Days In
CRISPR/Vertex gene editing therapy approved in U.S. for beta thalassemia